Stay updated on Baricitinib with Topical Steroids in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Baricitinib with Topical Steroids in Atopic Dermatitis Clinical Trial page.

Latest updates to the Baricitinib with Topical Steroids in Atopic Dermatitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe ClinicalTrials.gov record for the completed BREEZE-AD4 study is available, detailing its evaluation of baricitinib with topical corticosteroids for adults with moderate-to-severe atopic dermatitis and providing trial methods, eligibility criteria, and outcome measures.SummaryDifference100%

- Check16 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA banner announces NIH website transition updates and says some content may use “Super Intelligence” instead of “Artificial Intelligence.”SummaryDifference1%

- Check30 days agoChange DetectedThe footer’s site revision indicator changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer's site revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now renders a 403 Forbidden error with a minimal header and a Home button, indicating that the requested study record cannot be accessed in this view. This replaces the usual study details with an error screen.SummaryDifference23%

Stay in the know with updates to Baricitinib with Topical Steroids in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Baricitinib with Topical Steroids in Atopic Dermatitis Clinical Trial page.